Evidence map›Paper›PMID 16532973›Full record

ReviewJournal of the National Medical Association2006

The role of inhaled long-acting beta-2 agonists in the management of asthma.

H William Kelly, Michelle S Harkins, Homer Boushey

Abstract readReview
In one paragraph

Review in Journal of the National Medical Association, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

H William KellyDepartment of Pediatrics, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Michelle S Harkins
Homer Boushey

Funding

Mentored Patient-Oriented Research Career Development AwK23RR016079 · NCRR · UNIVERSITY OF NEW MEXICO · PI HARKINS, MICHELLE · 2000 to 2004
$637k
NCRR NIH HHS K23 RR 16079-05
6 · The paper itself

Abstract

The role of inhaled beta-2 agonists in the management of asthma has changed significantly over the last several years. This review outlines the most recent understanding of the pathophysiology of asthma and the studies that define the roles that both short- and long-acting beta-2 agonists play in therapy for this disease. A concentration on the clinical pharmacology and genetic implications for clinical use of this class of drugs in accordance with the national and international guidelines are described.

Indexed as

Administration, InhalationAdrenergic beta-AgonistsAnti-Asthmatic AgentsAsthmaHumansAdrenergic beta-AgonistsAnti-Asthmatic Agents

Identifiers

PMID16532973
PMCPMC2594808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.